C12orf25 Activators
C12orf25 Activators encompass a variety of chemical compounds that indirectly promote the functional activity of C12orf25 through distinct signaling pathways. For instance, Forskolin increases cAMP levels, subsequently activating PKA, which could phosphorylate proteins that are part of the activation process for C12orf25. A similar enhancement could occur through the action of Epigallocatechin gallate (EGCG), which inhibits competitive kinase pathways, possibly resulting in a more favorable activation environment for C12orf25. The activity of protein kinase C (PKC) is potentiated by Phorbol 12-myristate 13-acetate (PMA), potentially affecting signaling networks that include C12orf25. In parallel, PI3K inhibitors LY294002 and Wortmannin could shift cellular signaling in a manner that indirectly augments the functional role of C12orf25. Calciumionophores Ionomycin and A23187 dramatically increase intracellular calcium levels, potentially triggering calcium-dependent pathways that enhance C12orf25, assuming its activation is calcium-responsive. Additionally, the bioactive lipid Sphingosine-1-phosphate, through receptor-mediated signaling, and Thapsigargin, by disrupting calcium homeostasis, could also promote pathways where C12orf25 plays a role, thereby enhancing its activity.
The functional dynamics of C12orf25 are further influenced by chemical modulators that exert their effects on tyrosine kinase and MAPK signaling. Genistein, by inhibiting tyrosine kinase activity, may reduce competition for signaling components, potentially amplifying C12orf25's functional activity. Inhibition of specific MAPK pathway components by SB203580 and U0126, which target p38 MAPK and MEK1/2 respectively, could rebalance signaling cascades in favor of C12orf25 activation. These activators, through their targeted influence on cellular signaling networks, facilitate the upregulation of C12orf25-mediated functions. Collectively, C12orf25 Activators, by modulating various signaling pathways and cellular processes, ensure an enhanced activation state for C12orf25 without necessitating alterations in its expression levels or direct activation, thereby playing a critical role in the functional modulation of this protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea that acts as an antioxidant and has been shown to inhibit several protein kinases. By inhibiting competitive signaling pathways, EGCG might allow for the preferential activation of pathways involving C12orf25, consequently increasing its functional activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent protein kinase C (PKC) activator. PKC activation can lead to phosphorylation of proteins and modulation of signaling pathways that may include C12orf25, thereby potentially enhancing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K). By inhibiting PI3K, LY294002 can modulate downstream signaling pathways, which might lead to an indirect enhancement of C12orf25 activity if it is involved in these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, like LY294002. It leads to similar modulation of PI3K-dependent signaling pathways, potentially enhancing C12orf25 activity indirectly. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels and activates calcium-dependent signaling pathways. If C12orf25 is activated by calcium-dependent mechanisms, ionomycin could enhance its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore and antibiotic that increases intracellular calcium levels. This can lead to the activation of calcium-dependent signaling pathways, which may indirectly enhance the activity of C12orf25. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a bioactive lipid that activates signaling pathways through its receptors. It can modulate cellular processes potentially involving C12orf25, leading to its functional enhancement. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA). By altering calcium signaling, thapsigargin could indirectly enhance C12orf25 activity if it is involved in calcium-dependent processes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an isoflavone that functions as a tyrosine kinase inhibitor. It can alter signaling pathways by inhibiting competitive tyrosine kinase signaling, potentially allowing for enhanced activity of C12orf25. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. Inhibition of p38 MAPK can shift the balance of cellular signaling pathways, which might lead to enhanced activity of C12orf25 if it is implicated in pathways sensitive to p38 MAPK. | ||||||